Thomas Addison's disease after 154 years: Modern diagnostic perspectives on an old condition

QJM: An International Journal of Medicine

Volumn 102, Issue 8, 2009, Pages 569-573

  Leelarathna, Lalantha ^a   Powrie, J K ^a   Carroll, P V ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DICLOFENAC; FLUDROCORTISONE; GLUCOCORTICOID; GOLIMUMAB; HYDROCORTISONE; INFUSION FLUID; MINERALOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT; SODIUM; THYROXINE;

ABDOMINAL TENDERNESS; ACUTE KIDNEY FAILURE; ADDISON DISEASE; ADULT; ANOREXIA; ARTICLE; AUTOPSY; BACKACHE; BODY MASS; CASE REPORT; COUGHING; DIZZINESS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENERGY; FATIGUE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERKALEMIA; HYPONATREMIA; HYPOTENSION; HYPOTHYROIDISM; LENTIGO; MALE; MORTALITY; NAUSEA; PATIENT COUNSELING; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKIN PIGMENTATION; SYMPTOMATOLOGY; THYROID FUNCTION; TOOTH EXTRACTION; VOMITING; WEIGHT REDUCTION;

EID: 67949095859     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcp053     Document Type: Article

References (21)

1. Jeffcoate W. Thomas Addison: One of the three "Giants" of Guy's Hospital. Lancet 2005; 365:1989-90.
2. Addison T. On the Constitutional and Local Effects of Diseases of The Supra-Renal Capsules. London, Warren and Son, 1855.
3. Murray JS, Jayarajasingh R, Perros P. Lesson of the week: Deterioration of symptoms after start of thyroid hormone replacement. Br Med J 2001; 323:332-3.
4. Laureti S, Vecchi L, Santeusanio F, Falorni A. Is the incidence of Addison's disease underestimated? J Clin Endocrinol Metab 1999; 84:1762.
5. Lovas K, Husebye ES. High prevalence and increasing incidence of Addisons disease in Western Norway. Clin Endocrinol 2002; 56 787-91.
6. Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med 2004; 350:2068-79.
7. Marzotti S, Falorni A. Addisons's disease. Autoimmunity 2004; 37:333-6.
8. Elfström P, Montgomery SM, Kämpe O, Ekbom A, Ludvigsson JF. Risk of primary adrenal insufficiency in patients with celiac disease. J Clin Endocrinol Metab 2007; 92:3595-8.
9. Oelkers W. Adrenal insufficiency. N Engl J Med 1996; 335 1206-12.
10. Ten S, New M, Maclaren N. Clinical review 130: Addison's disease. J Clin Endocrinol Metab 2001; 86:2909-22.
11. Løvås K, Husebye ES. Addison's disease. Lancet 2005; 365 2058-61.
12. Bouillon R. Acute adrenal insufficiency. Endocrinol Metab Clin North Am 2006; 35:767-75.
13. Moallem M, Nader N, Auckley D. A 22-year-old woman with fever, jaw pain, and shock. Chest 2007; 132:1077-9.
14. Anglin RE, Rosebush PI, Mazurek MF. The neuropsychiatric profile of Addison's disease: Revisiting a forgotten phenomenon. J Neuropsych Clin Neurosci 2006; 18:450-9.
15. Bergthorsdottir R, Leonsson-Zachrisson M, Odén A, Johannsson G. Premature mortality in patients with Addison's disease: A population-based study. J Clin Endocrinol Metab 2006; 91 4849-53.
16. Bensing S, Brandt L, Tabaroj F, Sjöberg O, Nilsson B, Ekbom A, et al. Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clin Endocrinol 2008; 69:697-704.
17. Wood JB, James VHT, Frankland W. A rapid test of adrenocortical function. Lancet 1965; 285:243-5.
18. Grinspoon SK, Biller BM. Clinical review 62: Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 1994; 79 923-31.
19. Nieman LK, Chanco Turner ML. Addison's disease. Clin Dermatol 2006; 24:276-80.
20. Topliss DJ, White EL, Stockigt JR. Significance of thyrotropin excess in untreated primary adrenal insufficiency. J Clin Endocrinol Metab 1980; 50:52-6.
21. Falorni A, Laureti S, De Bellis A, Zanchetta R, Tiberti C, Arnaldi G, et al. Update of diagnostic criteria for the etiological classification of primary adrenal insufficiency. J Clin Endocrinol Metab 2004; 89:1598-604.